In recent years there have been a number of studies examining the association between coffee and its health benefits. Drinking coffee in moderation is said to offer protection against Parkinson disease, type 2 diabetes, colorectal cancer and Alzheimer's. And now, you can add one more to that list.
Novartis AG (NVS) said Friday that results of a pivotal Phase III trial in women with HER2 positive advanced breast cancer showed that Afinitor, or everolimus, tablets in combination with trastuzumab nd vinorelbine significantly extended progression-free survival after prior therapy when compared to...
Danish drug maker Novo Nordisk A/S (NVO) Friday announced positive results from the first Phase-3 trial with a long-acting FIX derivative, N9-GP, in the treatment of haemophilia B patients.
Haemophilia B a blood clotting disorder caused by a mutation of the Factor IX gene, leading to a deficiency...
French drugmaker Sanofi (SNY, SNYNF.PK) Friday announced that the Phase III study of Myelofibrosis inhibitor SAR302503 recorded greater 35 percent reduction in spleen volume, conforming its primary endpoint in both dose groups. The pivotal study named JAKARTA examined the selective JAK2 inhibitor and...
Non-melanoma skin cancer, which includes basal cell carcinoma and squamous cell carcinoma, is the most common type of cancer in the U.S. Now, here's a new research finding about this skin cancer.
The medical use of marijuana and its legalization have been hot topics of debate for decades. Although there is evidence that marijuana has value in treating people with cancer, AIDS or other terminal illnesses, marijuana continues to remain illegal and as a substance with no accepted medical use under Federal law in the United States.
Rockwell Medical Inc. (RMTI) has priced an underwritten public offering of its common stock at $3.05 each. With approximately 11.47 million shares to be offered for sale in the offering, the gross proceeds are estimated to be $35.0 million and net proceeds are projected to be about $32.8 million.
ACADIA Pharmaceuticals Inc. (ACAD) has priced the public offering of its common stock at $12.50 each. The company is selling 8 million shares in the offering, and the gross proceeds to ACADIA are expected to be $100 million, before deducting underwriting discounts and commissions and other estimated offering expenses.
Synthetic silicates, which are composed of simple or complex salts of silicic acids, are used in a wide range of industrial and consumer products, say food additives, glass and ceramic filler materials, and anti-caking agents. But that's not all as it has been found to have the potential for use in biomedical applications too.
Rotavirus is the leading cause of severe diarrhea among children worldwide. Children are immunized against rotavirus by either GlaxoSmithKline plc's (GSK) Rotarix or Merck & Co. Inc.'s (MRK) RotaTeq, both of which are oral vaccines.
Cocaine abuse remains a major public health problem in the U.S., with an estimated 1.4 million Americans addicted to the drug. Currently, there are no FDA-approved drugs to treat cocaine dependence while there is no denying the fact that extensive research is being conducted to develop new and effective treatments for this hard drug abuse.
Eli Lilly and Co. (LLY) said Friday that it will stop development of its experimental cancer drug enzastaurin after the medicine failed in a Phase III clinical trial that evaluated it as a monotherapy in the prevention of relapse in patients with diffuse large B-cell lymphoma.
The study, called PRELUDE,...
Cerebral malaria is the most severe form of malaria, and children are more susceptible to this life threatening disease. But if correctly diagnosed and given proper treatment, the patients are said to recover rapidly.
Baxter International Inc. (BAX) Tuesday said its Phase III clinical study of immunoglobulin or IG did not meet its co-primary endpoints of reducing cognitive decline and preserving functional abilities in patients with mild to moderate Alzheimer's disease.
The company said topline analyses from the...
Although getting gray hair is natural, not everyone likes to have it. As soon as the first strand of gray hair appears, people begin to color their hair. Now, here's a breakthrough finding that may spell excitement for people who are going gray but may stir worries among hair dye manufacturers.